Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.93 -0.02 (-0.29%)
As of: Sep 4, 2026 · 11:51 AM EDT

Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2026)

Ginkgo Bioworks Holdings' (DNA) quarterly Interest & Investment Income came in at -$78000.0 in Q1 2026, down 172.9% YoY from $107000.0 in Q1 2025, and down 100.35% on a QoQ basis from $22.3 million in Q4 2025.

Analysis

Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has 5 years of Interest & Investment Income data on file, last reported at -$78000.0 in Q1 2026.

  • Quarterly Interest & Investment Income fell 172.9% year-over-year to -$78000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (down 42.32% YoY) and the FY2025 annual result came in at $22.6 million, down 41.43% from the prior year.
  • Interest & Investment Income declined to -$78000.0 in Q1 2026, from $22.3 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $38.6 million in Q4 2024 to a low of -$78000.0 in Q1 2026.
  • A 3-year average of $12.2 million and a median of $316000.0 in 2025 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2025 — Interest & Investment Income slumped 42.31% — and 2026, when it sank 172.9%.
  • Tracing DNA's Interest & Investment Income over 3 years: stood at $38.6 million in 2024, then sank by 42.31% to $22.3 million in 2025, then slumped by 100.35% to -$78000.0 in 2026.
  • The last three Interest & Investment Income figures came in at -$78000.0 (Q1 2026), $22.3 million (Q4 2025), and $316000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 140.21 Bn 132.36 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.73 Bn 58.55 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.59 Bn 52.46 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 35.58 Mn
6 BeOne Medicines 40.13 Bn 35.04 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.55 Bn 32.24 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.60 Bn 27.77 Bn - 5.13 Mn
9 Insmed 27.70 Bn 26.54 Bn 358.27 Mn 10.98 Mn
10 Ginkgo Bioworks Holdings 430.31 Mn 345.78 Mn 18.44 Mn -210,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -210,000.00
Mar 31, 2026 -78,000.00
Dec 31, 2025 22.28 Mn
Sep 30, 2025 316,000.00
Jun 30, 2025 -83,000.00
Mar 31, 2025 107,000.00
Dec 31, 2024 38.61 Mn
Dec 31, 2021 496,000.00
Sep 30, 2021 121,000.00
Dec 31, 2020 -2.98 Mn
Sep 30, 2020 3.32 Mn